Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W Wirtz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|March 29, 2005
Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancerPaul W Wirtz, Axel R Wintzen, Jan J Verschuuren
Muscle & Nerve|June 11, 2011
Ultrasound-guided steroid injection to treat mild ulnar neuropathy at the elbowAnneke J J Rampen, Paul W Wirtz, Denes L J Tavy
Journal of Neurology|October 27, 2004
Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their familiesPaul W Wirtz, Jennifer Bradshaw, Axel R Wintzen, et al.
Clinical Neurology and Neurosurgery|July 26, 2002
Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published casesPaul W Wirtz, Thierry M Smallegange, Axel R Wintzen, et al.
Expert Review of Clinical Immunology|October 29, 2010
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndromePaul W Wirtz, Maarten J Titulaer, Joop Ma van Gerven, et al.
Muscle & Nerve|March 29, 2013
Accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosisM Omeed Fakiri, Dénes L J Tavy, Ako Dara Hama-Amin, et al.
Current Treatment Options in Neurology|December 25, 2012
Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotoniaAgnes van Sonderen, Paul W Wirtz, Jan J G M Verschuuren, et al.
Journal of Neuroimmunology|July 17, 2003
High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndromePaul W Wirtz, Tom W J Huizinga, Dirk-Jan Stoeken, et al.
Expert Opinion on Pharmacotherapy|June 30, 2006
Available treatment options for the management of Lambert-Eaton myasthenic syndromeJan J G M Verschuuren, Paul W Wirtz, Maarten J Titulaer, et al.
Muscle & Nerve|April 3, 2020
Meralgia paresthetica: Nerve stimulator-guided injection with methylprednisolone/lidocaine, a double-blind randomized placebo-controlled studyMark E Kloosterziel, Dénes L J Tavy, Samuel Arends, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|March 29, 2005
Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancerPaul W Wirtz, Axel R Wintzen, Jan J Verschuuren
Muscle & Nerve|June 11, 2011
Ultrasound-guided steroid injection to treat mild ulnar neuropathy at the elbowAnneke J J Rampen, Paul W Wirtz, Denes L J Tavy
Journal of Neurology|October 27, 2004
Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their familiesPaul W Wirtz, Jennifer Bradshaw, Axel R Wintzen, et al.
Clinical Neurology and Neurosurgery|July 26, 2002
Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published casesPaul W Wirtz, Thierry M Smallegange, Axel R Wintzen, et al.
Expert Review of Clinical Immunology|October 29, 2010
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndromePaul W Wirtz, Maarten J Titulaer, Joop Ma van Gerven, et al.
Muscle & Nerve|March 29, 2013
Accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosisM Omeed Fakiri, Dénes L J Tavy, Ako Dara Hama-Amin, et al.
Current Treatment Options in Neurology|December 25, 2012
Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotoniaAgnes van Sonderen, Paul W Wirtz, Jan J G M Verschuuren, et al.
Journal of Neuroimmunology|July 17, 2003
High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndromePaul W Wirtz, Tom W J Huizinga, Dirk-Jan Stoeken, et al.
Expert Opinion on Pharmacotherapy|June 30, 2006
Available treatment options for the management of Lambert-Eaton myasthenic syndromeJan J G M Verschuuren, Paul W Wirtz, Maarten J Titulaer, et al.
Muscle & Nerve|April 3, 2020
Meralgia paresthetica: Nerve stimulator-guided injection with methylprednisolone/lidocaine, a double-blind randomized placebo-controlled studyMark E Kloosterziel, Dénes L J Tavy, Samuel Arends, et al.
Pageof 3